The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach. – Logos Biosystems | Advanced Imaging Solutions for Research Excellence

Products

< Back

Customer Reviews

< Back

Resources

< Back

Support

< Back

About Us

< Back

The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach.

2022-07-06

2022. Puylaert P, Coornaert I, Neutel CH, Dondelinger Y, Delanghe T, Bertrand MJ, … & Martinet W. Biomedicines, 10(5), 1016.